SVT Keeps Striking, Your Doctors Can't Explain Why. Your Genes Can.

Your heart’s electrical system relies on precise timing. Sodium ions rush into heart cells, creating the electrical impulse that makes your heart contract. The SCN5A gene codes for the sodium channel that controls this flow. When it works normally, sodium enters and exits in perfect rhythm, and your heart beats steadily.

SCN5A variants make this gate less stable. The channel might open too easily, close too slowly, or stay partially open when it should be shut. Because roughly 1-3% of people with SVT carry SCN5A mutations, and many more carry subtle variants that alter channel sensitivity, this gene shows up repeatedly in recurrent arrhythmia cases. A dysfunctional sodium channel can cause your heart to spontaneously depolarize, triggering an ectopic beat that ignites the entire SVT episode.

You might notice your SVT starts after exercise or sudden stress, sometimes triggered by nothing you can identify. Your heart feels irritable, like it’s looking for an excuse to race. Caffeine or sudden posture changes might set it off. Some days are worse than others for no obvious reason. That unpredictability is classic SCN5A dysfunction, because the channel’s instability varies with body temperature, electrolyte levels, and autonomic tone.

While sodium rushes in to start the heartbeat, potassium flows out to end it. The KCNQ1 gene codes for a potassium channel that acts as the electrical brake, resetting the heart cell so it can fire again. When potassium outflow is normal, the electrical pulse duration stays tight and controlled.

KCNQ1 variants lengthen the time it takes for a heart cell to fully reset. The electrical pulse lingers. Cells stay partially depolarized. This creates a substrate where abnormal impulses can propagate more easily. Roughly 2-5% of SVT cases involve KCNQ1 mutations, and the condition often runs in families. A slowed potassium channel gives ectopic beats more opportunity to spread and sustain, converting a single misfire into a full arrhythmia episode.

You might experience SVT that builds gradually rather than starting suddenly. It feels like your heart is warming up into the arrhythmia, and it takes longer to break out of it once it starts. You might also be more sensitive to electrolyte imbalances, feeling palpitations when you’re dehydrated or after sweating heavily. Some people with KCNQ1 variants notice their SVT worsens during menstrual cycle changes or with certain medications.

Nitric oxide is a signaling molecule that tells your blood vessels to relax and dilate. The NOS3 gene codes for endothelial nitric oxide synthase, the enzyme that produces it. When working normally, NOS3 helps blood vessels respond fluidly to your body’s demands, maintain healthy blood pressure, and modulate heart rate variability.

The Glu298Asp variant in NOS3 impairs this enzyme’s function, reducing nitric oxide production. Roughly 30-40% of the population carries this variant. With reduced nitric oxide, your blood vessels stay stiffer, your baseline blood pressure rises, and your heart becomes more irritable because it’s always operating under higher mechanical stress.

You might notice your SVT episodes are more common when your blood pressure is elevated, during high-stress periods, or after poor sleep. Your resting heart rate might be chronically elevated. You may have been told you have mild hypertension or prehypertension. During episodes, your heart seems to overreact to minor triggers like standing up quickly or emotional moments. This is because the vascular stiffness and reduced blood vessel feedback control makes your heart’s electrical system more reactive.

The ACE gene codes for an enzyme that converts angiotensin I into angiotensin II, a powerful vasoconstrictor. This system helps regulate blood pressure, electrolyte balance, and fluid retention. When functioning normally, ACE keeps this system in balance.

The D/D variant of the ACE insertion/deletion polymorphism increases enzyme activity. People homozygous for the D allele, roughly 25% of the population, have higher ACE activity, higher angiotensin II levels, and elevated baseline blood pressure. Higher angiotensin II makes blood vessels constrict more aggressively, increases cardiac workload, and promotes cardiac tissue remodeling that makes arrhythmias more likely.

You might have had blood pressure readings that hover in the high-normal to mild hypertension range, especially during stress. Your SVT episodes might follow periods of salt intake, dehydration, or emotional stress, because the D/D genotype makes you salt-sensitive. Your heart feels more reactive to caffeine and stimulants. Doctors may have noticed some degree of left ventricular hypertrophy (thickened heart wall) on imaging, even if mild, because the chronic higher blood pressure pushes your heart to work harder.

During stress, your body releases adrenaline and noradrenaline to prepare for action. The COMT enzyme breaks these stress hormones down and clears them from your bloodstream. When COMT works efficiently, stress hormones spike and then fall, allowing your nervous system to settle.

The Val158Met variant in COMT creates a slow version of this enzyme. People homozygous for the Met allele, roughly 25% of people with European ancestry, have 40-50% lower COMT activity. Stress hormones linger in your bloodstream longer, keeping your nervous system in a state of heightened reactivity, which directly increases your heart’s electrical irritability.

You might notice your SVT episodes cluster during stressful periods, or that anxiety and palpitations feel almost inseparable. Caffeine feels like it lasts much longer for you than for other people; one cup in the morning keeps you wired all day. Exercise or stressful situations trigger your SVT more predictably than they should. Your baseline heart rate is elevated, even at rest. You’ve been told you have anxiety, and it’s always seemed tied to your heart symptoms, not separate from them.

MTHFR catalyzes a critical step in converting dietary folate into its active form, which enters the methylation cycle. This cycle affects homocysteine levels, neurotransmitter production, nitric oxide synthesis, and energy production in mitochondria. When MTHFR works efficiently, homocysteine is kept low and one-carbon metabolism hums along.

The C677T variant in MTHFR reduces enzyme activity by 35-40%. Roughly 40% of people of European ancestry carry at least one copy. Reduced MTHFR activity allows homocysteine to accumulate, which damages blood vessel endothelium, increases thrombosis risk, and impairs nitric oxide production, all of which can trigger or worsen SVT.

You might have noticed elevated homocysteine on bloodwork, or your doctors have mentioned it in passing as a cardiovascular risk factor. You might also struggle with energy levels, brain fog, or mood instability, because impaired methylation affects dopamine and serotonin synthesis. Some people with MTHFR variants notice their SVT worsens when B vitamin intake is low, or improves when they supplement with activated forms. Your palpitations might be worse on days when you feel more fatigued or mentally foggy.